Anti-EGFR Agents Are Effective in Older Patients With RAS Wild-Type Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years
Eur. J. Cancer 2022 Mar 01;163(xx)1-15, D Papamichael, GS Lopes, CL Olswold, JTY Douillard, RA Adams, TS Maughan, E Van Cutsem, AP Venook, HJ Lenz, V Heinemann, R Kaplan, C Bokemeyer, B Chibaudel, A Grothey, T Yoshino, J Zalcberg, A De Gramont A, Q ShiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.